Another important finding we made in this study is that IMP3 is validated as an independent prognostic marker for localized CCRCC, which is concluded based on comprehensive analyses of our large cohort of localized CCRCC patients. Here, IMP3 is linked to nonpapillary renal cell carcinoma.